Ajoene, a major compound containing sulfur in oilmacerated garlic products, inhibited in a two-stage carcinogenesis test on mouse skin. Treatment with ajoene suppressed skin tumor formation, depending on the amount. In particular, the group treated with 250 mg of ajoene had only 4.9% the number of tumors per mouse compared with the control group at 18 weeks.
Garlic ( Allium sativum L.) has been used worldwide as a food and medicinal plant since ancient times, and its beneˆcial properties against cardiovascular diseases, cancer, and infections are well known. 1) Epidemiological studies have shown its usefulness against several kinds of cancer. [2] [3] [4] [5] However, the identity of the eŠective compounds in garlic, is not known; they change depending on cooking and processing procedures. 6) Maceration in oil is one method for processing garlic, and this product is widely used as a health food in Europe. 7) Ajoene [( E,Z )-4,5,9-trithiadodeca-1,6,11-triene-9-oxide] ( Fig. 1) , one of the derivatives of allicin, is a major compound containing sulfur in oil-macerated garlic products, and has antithrombic 8) and antibiotic [9] [10] [11] [12] [13] eŠects. We have reported on the antimutagenic eŠects of ajoene against benzo[a]pyrene with Salmonella typhimurium. 14) However, antitumor eŠects have not been reported on, so we tested the antitumor eŠects of ajoene in a two-stage carcinogenesis test on mouse skin.
15)
Z-ajoene more than 98z pure was used. Preparation and the check of purity were done by the methods of Block et al. 8) and Lawson et al., 7) respectively. 7,12-Dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) were purchased from Wako Pure Chemical Industries (Osaka, Japan). All chemicals including solvents used were of the highest grade commercially available.
Male ICR mice, 7 weeks old, were obtained from Japan SLC Co. (Shizuoka, Japan). The animals, weighing 32-35 g, were housed individually in plastic cages in a room kept at 23-259 C and about 50z humidity, with a 12-h light-dark cycle, and provided with water and standard laboratory feed during the experiment. The back of each mouse was shaved with surgical clippers, and a chemical was applied to a 3-cm 2 area. All of the mice were carcinogenically initiated with DMBA (50 mg, 190 nmol) in acetone (0.2 ml). Starting 1 week later, carcinogenic growth was promoted twice a week by the application of TPA (1 mg, 1.6 nmol) in acetone (0.2 ml) on the same place. At the same time, mice were divided into four groups, each containing at leastˆve mice: group I, the positive controls, was given TPA (1.6 nmol) in acetone (0.2 ml) alone. Groups II, III, and IV were treated with ajoene (50, 100, or 250 mg, respectively) in acetone 1 h before each TPA treatment. The incidence of tumors was observed weekly for 18 weeks, and the percentages of mice bearing tumors and the mean number of tumors per mouse were calculated. The animal experiments were done according to institutional guidelines of the Committee on Animal Research at Nagoya Seiraku.
Results are given as means±SE. Statistical analy- Results at 18 weeks are given as means±SE. a Each group hadˆve mice. * Signiˆcantly diŠerent from the control group ( Pº0.05). ** Signiˆcantly diŠerent from the control group ( Pº0.01).
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sis of the diŠerences between the means of tumors per mouse was done by Student's t-test. DiŠerences with Pº0.05 were considered to be signiˆcant. 16) The eŠects of ajoene on two-stage carcinogenesis of mouse skin are shown in Fig. 2 and Table 1 . All 5 positive controls in group I, bore tumors as of 10 weeks, and the mean number of tumors per mouse was more than 10 by 18 weeks. In group II treated with 50 mg of ajoene, 80z of the mice bore tumors, and a mean of 4.0 tumors had formed per mouse by 18 weeks. With tumor formation of the positive controls as 100z, such formation was inhibited by 67.2z. With 250 mg of ajoene (group IV), at 18 weeks, a mean of 0.6 had formed per mouse, and inhibition was 95.1z. Treatment with ajoene inhibited later tumor formation, with eŠects dependent on the dose, and the eŠect of 250 mg was signiˆcant.
Oil-macerated garlic products contain 500 to 1000 mg W g of ajoene if prepared from two parts of garlic and one part of vegetable oil (unpublished data). Lawson has reported on the stability of compounds in such products; ajoene in gelatin capsules loses 1.5z per month at room temperature. These results allow the use of ajoene as a health food.
Ajoene protected strongly against TPA-promoted carcinogenesis on mouse skin. This compound is one of the active constituents of the eŠects of garlic against tumor promotion.
